(Q44494801)

3 December 2017

Compensating effects on the cytotoxicity of ribonuclease A variants (English)

1 reference

3 December 2017

0 references

3

1 reference

3 December 2017

1

Kimberly A Dickson

1 reference

3 December 2017

Caroline L Dahlberg

2

1 reference

PubMed ID

12831839

3 December 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Archives of Biochemistry and Biophysics

3 December 2017

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

3 December 2017

415

1 reference

3 December 2017

2

1 reference

3 December 2017

172-177

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900214-5

3 December 2017

1 reference

Phase II trial of a single weekly intravenous dose of ranpirnase in patients with unresectable malignant mesothelioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900214-5

Ribonuclease A variants with potent cytotoxic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900214-5

A ribonuclease A variant with low catalytic activity but high cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900214-5

Conformational Stability Is a Determinant of Ribonuclease A Cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900214-5

Endowing human pancreatic ribonuclease with toxicity for cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900214-5

Cancer chemotherapy--ribonucleases to the rescue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900214-5

Refined 1.7 A X-ray crystallographic structure of P-30 protein, an amphibian ribonuclease with anti-tumor activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900214-5

Ribonuclease a: revealing structure-function relationships with semisynthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900214-5

A synapomorphic disulfide bond is critical for the conformational stability and cytotoxicity of an amphibian ribonuclease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900214-5

A structural basis of the interactions between leucine-rich repeats and protein ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900214-5

Role of the N terminus in RNase A homologues: differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900214-5

Protein chemical and kinetic characterization of recombinant porcine ribonuclease inhibitor expressed in Saccharomyces cerevisiae.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900214-5

Mechanism of ribonuclease inhibition by ribonuclease inhibitor protein based on the crystal structure of its complex with ribonuclease A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900214-5

Engineering ribonuclease A: production, purification and characterization of wild-type enzyme and mutants at Gln11.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900214-5

The correlation of ribonuclease activity with specific aspects of tertiary structure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900214-5

High-Level Soluble Production and Characterization of Porcine Ribonuclease Inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900214-5

Contribution of a tyrosine side chain to ribonuclease A catalysis and stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900214-5

Hypersensitive substrate for ribonucleases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900214-5

Fluorescence assay for the binding of ribonuclease A to the ribonuclease inhibitor protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900214-5

KFERQ sequence in ribonuclease A-mediated cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900214-5

Optimum modification for the highest cytotoxicity of cationized ribonuclease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900214-5

Ribonuclease inhibitor as an intracellular sentry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900214-5

Macromolecular crowding: obvious but underappreciated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900214-5

Estimation of macromolecule concentrations and excluded volume effects for the cytoplasm of Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900214-5

10.1016/S0003-9861(03)00214-5

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference

PubMed ID

12831839